NADPH oxidase regulates efficacy of vaccination in aspergillosis.
Where this comes from
- Record sourced from PubMed, PMID 22523062.
- Also identified by DOI 10.1172/JCI63417 and PMC identifier 3337002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Invasive aspergillosis is often a consequence of immune suppression, and accumulating evidence points to a role for adaptive immunity. Hence, it may be possible to manipulate the adaptive immune system to enhance protective immunity in at-risk individuals. In this issue of the JCI, De Luca and colleagues describe the ontogeny of adaptive immune responses to murine aspergillosis infection in relation to vaccination. Their thought-provoking findings reveal the complexities of vaccine-induced immunity and could be used to improve vaccine efficacy.
Medical subject headings
- Antigens, Fungal
- Cross-Priming
- Granulomatous Disease, Chronic
- Vaccination